Microfluidic-assisted fabrication of reverse micelle/PLGA hybrid microspheres for sustained vascular endothelial growth factor delivery.

Biotechnology and Applied Biochemistry
Meisam OmidiLobat Tayebi

Abstract

In this study, poly (d, l-lactide-co-glycolide) (PLGA) composite microspheres containing anhydrous reverse micelle (R.M.) dipalmitoylphosphatidylcholine (DPPC) nanoparticles loaded vascular endothelial growth factor (VEGF) were produced using microfluidic platforms. The VEGF-loaded R.M. nanoparticles (VRM) were achieved by initial self-assembly and subsequent lipid inversion of the DPPC vesicles. The fabricated VRMs were encapsulated into the PLGA matrix by flow-focusing geometry microfluidic platforms. The encapsulation efficiency, in vitro release profile, and the bioactivity of the produced composite microspheres were investigated. The release study showed that VEGF was slowly released from the PLGA composite microspheres over 28 days with a reduced initial burst (18  ±  4.17% in the first 24 H). The VEGF stability during encapsulation and release period was also investigated, and the results indicated that encapsulated VEGF was well preserved. Also, the bioactivity assay of the PLGA composite microspheres on human umbilical vein endothelial cells was confirmed that the encapsulated VEGF was utterly active. The present monodisperse and controllable VEGF-loaded microspheres with reproducible manner could be widely used in tis...Continue Reading

References

Nov 12, 1998·The American Journal of Pathology·C ZietzU Löhrs
Dec 10, 1999·The Journal of Clinical Investigation·N van BruggenN Ferrara
Aug 23, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·M Diwan, T G Park
Oct 1, 2003·Angiogenesis·A P AdamisR A D'Amato
Dec 12, 2003·Nature Reviews. Drug Discovery·Michael Simons, J Anthony Ware
Apr 6, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·J SiepmannJ P Benoit
Mar 19, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chandrashekar RamanDaniel W Pack
Sep 27, 2005·Advanced Drug Delivery Reviews·Michael I UgwokeRenaat Kinget
Dec 16, 2005·Nature·Peter Carmeliet
Mar 31, 2007·Nature Reviews. Drug Discovery·Judah Folkman
May 29, 2007·Microvascular Research·Arindel S R Maharaj, Patricia A D'Amore
Dec 7, 2007·International Journal of Pharmaceutics·D KloseJ Siepmann
Dec 11, 2007·Nanomedicine : Nanotechnology, Biology, and Medicine·Awesh Kumar YadavGovind Prasad Agrawal
Oct 7, 2008·International Journal of Pharmaceutics·Weien YuanTuo Jin
May 22, 2009·Nature Materials·Elsie S PlaceMolly M Stevens
Mar 17, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Justin S GolubRobert E Guldberg
Jul 21, 2012·International Journal of Pharmaceutics·Teresa Simón-YarzaMaría J Blanco-Prieto
Oct 27, 2015·Colloids and Surfaces. B, Biointerfaces·Claudia da Silva BitencourtLúcia Helena Faccioli
Jun 28, 2016·Colloids and Surfaces. B, Biointerfaces·Tiankui QiaoXuesi Chen
Jun 29, 2016·Expert Opinion on Drug Delivery·Lungile Nomcebo ThwalaNoémi Stefania Csaba
Aug 31, 2016·British Journal of Cancer·Madelon Q WentinkHenk M W Verheul
Oct 31, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rick VisserJose Becerra
Nov 15, 2016·International Journal of Pharmaceutics·Mariana Guimarães Sá CorreiaDimitrios A Lamprou
Dec 25, 2016·Colloids and Surfaces. B, Biointerfaces·Ming-Mao ChenWen-Zhi Yang
Mar 28, 2017·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lin SunYing Zheng
Aug 12, 2017·Colloids and Surfaces. B, Biointerfaces·Maria MirAsim Ur Rehman
Sep 19, 2017·Advanced Drug Delivery Reviews·Sharma T SanjayXiuJun Li

❮ Previous
Next ❯

Citations

Jul 13, 2021·Frontiers in Bioengineering and Biotechnology·Aurelio Salerno, Paolo A Netti
Aug 19, 2021·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Guorong JiaKai Chen
Aug 20, 2021·Nano-micro Letters·Maedeh RahimnejadRajender S Varma
Jun 1, 2021·Journal of Tissue Engineering and Regenerative Medicine·Daniela Santos Masson-Meyers, Lobat Tayebi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.